Neuraminidase Delivered as an APC-Targeted DNA Vaccine Induces Protective Antibodies against Influenza

Researchers reported that protection was mainly mediated by antibodies, although neuraminidase-specific T cells also contributed. Both antigen-presenting cells-targeting and antigen bivalency were crucial for vaccine efficacy.